Gri2icg0syq0lqfykc5y phar

Partnership for Health Analytic Research (PHAR), LLC

Beverly Hills, California, US

Founded in 2004, PHAR is a boutique consultancy dedicated to the practice of health services. We are physician-led, allowing us to bring both clinical experience and methodological expertise to every project. Each study commands the attention of a team of senior-level experts, ensuring flawless execution at every stage of every project.

Recent Publications

  • Broder MS, Chang E, Ludlam WH, Neary MP, Carmichael JD. Patterns of pharmacologic treatment in US patients with acromegaly. Curr Med Res Opin. 2016 May;32(5):799-805. doi: 10.1185/03007995.2015.1125870.
  • Raimundo K, Chang E, Broder MS, Alexander K, Zazzali J, Swigris JJ. Clinical and economic burden of idiopathic pulmonary fibrosis: a retrospective cohort study. BMC Pulm Med. 2016 Jan 5;16:2. doi: 10.1186/s12890-015-0165-1.
  • Broder MS, Chang E, Romanus D, Cherepanov D, Neary MP. Healthcare and economic impact of diarrhea in patients with... Show more »

Founded in 2004, PHAR is a boutique consultancy dedicated to the practice of health services. We are physician-led, allowing us to bring both clinical experience and methodological expertise to every project. Each study commands the attention of a team of senior-level experts, ensuring flawless execution at every stage of every project.

Recent Publications

  • Broder MS, Chang E, Ludlam WH, Neary MP, Carmichael JD. Patterns of pharmacologic treatment in US patients with acromegaly. Curr Med Res Opin. 2016 May;32(5):799-805. doi: 10.1185/03007995.2015.1125870.
  • Raimundo K, Chang E, Broder MS, Alexander K, Zazzali J, Swigris JJ. Clinical and economic burden of idiopathic pulmonary fibrosis: a retrospective cohort study. BMC Pulm Med. 2016 Jan 5;16:2. doi: 10.1186/s12890-015-0165-1.
  • Broder MS, Chang E, Romanus D, Cherepanov D, Neary MP. Healthcare and economic impact of diarrhea in patients with carcinoid syndrome. World J Gastroenterol. 2016 Feb 14;22(6):2118-25. doi: 10.3748/wjg.v22.i6.2118.
  • Broder MS, Chang E, Cherepanov D, Neary MP, Ludlam WH. Identification of potential markers for Cushing Disease. Endocr Pract. 2016 May;22(5):567-74. doi: 10.4158/EP15914.OR.
  • Broder MS, Sarsour K, Chang E, Collinson N, Tuckwell K, Napalkov P, Klearman M. Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysis. Semin Arthritis Rheum. 2016 Oct;46(2):246-52. doi: 10.1016/j.semarthrit.2016.05.009.
  • Bickel KE, McNiff K, Buss MK, Kamal A, Lupu D, Abernethy AP, Broder MS, Shapiro CL, Acheson AK, Malin J, Evans T, Krzyzanowska MK. Defining High-Quality Palliative Care in Oncology Practice: An American Society of Clinical Oncology/American Academy of Hospice and Palliative Medicine Guidance Statement. J Oncol Pract. 2016 Sep;12(9):e828-38. doi: 10.1200/JOP.2016.010686.
  • Luskin AT, Antonova EN, Broder MS, Chang EY, Omachi TA, Ledford DK. Health care resource use and costs associated with possible side effects of high oral corticosteroid use in asthma: a claims-based analysis. Clinicoecon Outcomes Res. 2016 Oct 25;8:641-648.
  • Broder MS, Neary MP, Chang E, Cherepanov D, Ludlam WH. Burden of illness, annual healthcare utilization, and costs associated with commercially insured patients with Cushing disease in the United States. Endocr Pract. 2015 Jan;21(1):77-86. doi: 10.4158/EP14126.OR.
  • Cramer JA, Wang ZJ, Chang E, Copher R, Cherepanov D, Broder MS. Health-care costs and utilization related to long- or short-acting antiepileptic monotherapy use. Epilepsy Behav. 2015 Mar;44:40-6. doi: 10.1016/j.yebeh.2014.12.020.
« Show less

Partnership for Health Analytic Research (PHAR), LLC has not listed any services.

Health Economic Modeling
Price on request
Request a quote for more information about this service.
Healthcare Research and Analytics
Price on request

Understanding patterns of health care use is a core aspect of health services research. Most “patterns of care” studies focus on one or more specific care component: cost of care, quality in relation to guidelines, persistence and compliance, and drug or other health service utilization. PHAR, LLC has developed a proprietary... Show more »

Understanding patterns of health care use is a core aspect of health services research. Most “patterns of care” studies focus on one or more specific care component: cost of care, quality in relation to guidelines, persistence and compliance, and drug or other health service utilization. PHAR, LLC has developed a proprietary method of graphical analysis called GRAPHx to improve the interpretability of these kinds of studies. Using patient-level, high-resolution graphics, we can create single-page images that illustrate thousands of patient histories. When combined with more traditional analyses, these graphical summaries give us deeper insight into common health care practices.

The PHAR, LLC outcomes research conducts a variety of study types, including systematic literature reviews, primary data collection with retrospective or prospective patient chart reviews, physician surveys, as well as secondary data analyses using major commercial-insurance databases and other data sources. The group disseminates study findings in a variety of forums to provide payers, clinicians, and researchers with novel and timely data on a variety of important health services research topics.

In addition to our proprietary data visualization tool, we also conduct:

  • Systematic literature reviews
  • Meta-analyses, and indirect comparisons of a wide range of clinical and economic outcomes
  • Studies of the impact of compliance and persistence on clinical and economic outcomes
  • Assessments of healthcare quality using primary and secondary data
  • Validation of claims-based algorithms for patient identification
  • Patient-reported outcome measure validation
  • Patient-reported outcome dossiers
« Show less
Health Economics and Outcomes Research (HEOR)
Price on request

Articulating a strategy to demonstrate a product’s value requires careful consideration of the marketplace, a product’s attributes, and the competitive landscape. The health economic tactics needed to execute this strategy can be considered only after such a plan has been laid out. Every PHAR, LLC project begins with a... Show more »

Articulating a strategy to demonstrate a product’s value requires careful consideration of the marketplace, a product’s attributes, and the competitive landscape. The health economic tactics needed to execute this strategy can be considered only after such a plan has been laid out. Every PHAR, LLC project begins with a careful assessment of our client’s needs, the competitive landscape and the product strategy. Our combination of clinical and economic experience then allows us to bring a big picture focus to every project, regardless of size or budget.

The health economics group at PHAR, LLC uses cost effectiveness and budget impact analyses to help clients in the life sciences industry establish value for their products. Our clinically-relevant, transparent models are populated with real world data and demonstrate to payers, clinicians, and researchers the economic and health-related impact of various technologies and products.

Our health economic services include:

  • Cost-effectiveness and decision models using both Excel and TreeAge
  • Interactive budget-impact models to communicate with clinicians and payers.
  • AMCP style dossiers
  • Cost of noncompliance studies
  • Burden-of-illness studies
  • Comparative cost and utilization studies using a wide variety of advanced statistical techniques
« Show less
Genomics Consulting
Price on request

The sequencing of the human genome and the development of low cost microarrays have led to a proliferation of tests of gene expression in many cancers, many of which tests are designed to predict recurrence and guide treatment. Other assays guide the selection of chemotherapeutic regimens. Medicare and private payer... Show more »

The sequencing of the human genome and the development of low cost microarrays have led to a proliferation of tests of gene expression in many cancers, many of which tests are designed to predict recurrence and guide treatment. Other assays guide the selection of chemotherapeutic regimens. Medicare and private payer reimbursement of these tests depends on providing evidence of 3 types of validity: analytic validity, clinical validity, and clinical utility. PHAR, LLC has a proven track record of developing methodologically sound evidence of clinical utility for a variety of genomic tests, as well as extensive experience in developing tools to communicate these results with managed care payers.

Services relevant to the genomics industry include:

  • Prospective studies of the impact of genomic testing on treatment
  • Medical record review studies comparing pre- and post-testing recommendations
  • Comparisons of assay-based recommendations to national guidelines
  • Systematic literature reviews of clinical utility studies
  • Interactive budget impact models of the cost of genomic tests
  • Cost-effectiveness models of genomic testing compared to usual care
« Show less
Business Development Consulting
Price on request

Using a well tested, rigorous method can help organizations draw on expert advisors to formulate strategy. A quantitative method, called the Delphi process, improves information gathering and decision making. This method was described in Harvard Business Review as a way to develop “highly useful strategic guidelines.” We have used... Show more »

Using a well tested, rigorous method can help organizations draw on expert advisors to formulate strategy. A quantitative method, called the Delphi process, improves information gathering and decision making. This method was described in Harvard Business Review as a way to develop “highly useful strategic guidelines.” We have used it to help companies determine whether new clinical trials are likely to be worth their cost; to determine the direction of marketing campaigns; to develop classification systems and terminology for common diseases; to develop appropriateness of various treatments for a particular type of patient; and to set standards for economic analyses. In such situations, traditional processes for problem solving had not been fruitful, but the Delphi panel method was able to produce meaningful results.

Other strategic consulting services include:

  • Advisory boards
  • Strategic plan development
  • Consulting services
  • Competitive message evaluation
  • Publication planning and implementation
  • Value proposition development
« Show less
Project Management
Price on request
Request a quote for more information about this service.
Assay Development
Price on request
Request a quote for more information about this service.
Clinical Research
Price on request
Request a quote for more information about this service.
Epidemiology, HEOR, and Post-Authorization Studies
Price on request
Request a quote for more information about this service.

Partnership for Health Analytic Research (PHAR), LLC has not received any ratings.

Be the first to endorse Partnership for Health Analytic Research (PHAR), LLC

Endorse this lab